The board of NT PHARMA (01011) has announced a change in its chief executive leadership.
Mr. Zhang Bozhi has resigned from his position as Chief Executive Officer, effective July 3, 2026, in order to dedicate more time to his personal and other affairs.
Following his resignation, Mr. Zhang will no longer hold any position within the company or any of its subsidiaries.
Mr. Wu Jingjie has been appointed as the company's Chief Executive Officer, with the appointment also taking effect from July 3, 2026.